return to news
  1. Anthem Biosciences IPO: Issue booked nearly 64x on day 3, QIBs take lead; here's how to check allotment

Market News

Anthem Biosciences IPO: Issue booked nearly 64x on day 3, QIBs take lead; here's how to check allotment

Upstox

3 min read | Updated on July 16, 2025, 18:05 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

The portion reserved for qualified institutional buyers '(QIBs) saw the highest response with 182.65 times of subscription, followed by the non-institutional investors (NIIs), which was booked 42.35 times at the end of the last day of IPO.

Anthem Biosciences IPO allotment is likely to be finalised on July 17. | Image: anthembio.com

Anthem Biosciences IPO allotment is likely to be finalised on July 17. | Image: anthembio.com

Anthem Biosciences Day 3: The initial public offering (IPO) of Anthem Biosciences saw a good response on the last day of the bidding process on Wednesday, July 16.

According to NSE data until 5 PM, the issue was subscribed 63.86 times, with total bids received for 28,144,347,40 shares against the offered 4,407,0682 shares.

The portion reserved for qualified institutional buyers '(QIBs) saw the highest response with 182.65 times of subscription, followed by the non-institutional investors (NIIs), which was booked 42.35 times at the end of the last day of IPO. The retail investors' portion was subscribed 5.64 times.

The initial public offering of Anthem Biosciences Ltd opened for public subscription on Monday, July 14. The initial share sale, with a price band of ₹540 to ₹570 per share, will end on July 16.

The issue is looking to raise ₹3,395 crore via the offer for sale of 5.96 crore shares. The company will not get any IPO proceeds, as there is no fresh issuance of shares. The money generated will go to selling shareholders.

Last week, Anthem Biosciences collected ₹1,016 crore in the anchor round from investors, including Abu Dhabi Investment Authority, Eastspring Investments, Government Pension Fund Global, Amundi Funds, PineBridge Global Funds, Societe Generale, HDFC Mutual Fund (MF), Axis MF, UTI MF, Quant MF, and ICICI Prudential MF.

The firm allocated 1.78 crore shares to 60 funds at ₹570 per unit at the upper price band.

Anthem Biosciences IPO allotment is likely to be finalised on July 17. The company's shares will debut on the NSE and the BSE on July 21.

Steps to check Anthem Biosciences IPO allotment status on NSE
• Visit the NSE IPO allotment status page at https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids

• Chose ‘Equity & SME IPO bid details’

• Select Anthem Biosciences from the list of IPO names

• Enter your application number and PAN details.

• Click ‘Submit’ to view the status of your IPO allotment.

Steps to check Anthem Biosciences IPO allotment status BSE
• Visit the BSE IPO allotment status page: https://www.bseindia.com/investors/appli_check.aspx

• Select ‘Anthem Biosciences’ as the issue type.

• From the dropdown menu, select ‘Anthem Biosciences.’ Identify yourself using either PAN details or the IPO application number.

• Click on the ‘I’m not a robot’ tab and press the ‘Search’ button to see the allotment details.

Anthem Biosciences IPO GMP
According to investorgain.com, Anthem Biosciences unlisted shares are trading at ₹732, reflecting a grey market premium (GMP) of 28.42% or ₹162 over the issue price of ₹570.
Disclaimer: Grey Market Premium, or GMP, is an unofficial indicator of market sentiment toward an IPO. It is not regulated by the stock exchanges or SEBI. Upstox neither supports nor encourages grey market trading. Investors are advised to conduct their own research or consult an expert before making any investment decisions.
SIP
Consistency beats timing.
promotion image

About The Author

Upstox
Upstox News Desk is a team of journalists who passionately cover stock markets, economy, commodities, latest business trends, and personal finance.